Joel Lewis, President and CEO at GALECTIN THERAPEUTICS INC (GALT), bought 1,000 shares at $3.39 ($3K) on 2024-04-24, disclosed to the SEC on 2024-04-25.
Seasonal purchase ($3k) by President and CEO — this insider has traded GALT in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| GALT | SELL | 2025-11-19 | $231K | — | Filing → |
| GALT | SELL | 2025-11-12 | $11K | — | Filing → |
| GALT | SELL | 2025-11-07 | $1K | — | Filing → |